Physician

Ersilia M. Defilippis, M.D.

According to 2025 Medicare claims, Ersilia Defilippis, M.D. (NPI: 1073994208) practices advanced heart failure and transplant cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (NPI: 1861907321; TIN: 135598093) and primary practice location at 10032-3720. Defilippis is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Defilippis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 169 traditional Medicare patients, billed 589 HCPCS/CPT codes, and received $57,923 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 400 prescription claims across 71 beneficiaries totaling $140,102 in drug costs, led by Entresto (Sacubitril/Valsartan). 2023 DME data shows 84 claims. Open Payments data shows 62 records totaling $9,542. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $8,802 to $140,102. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	84	384	$33,040
2023	103	396	$38,461
2024	169	589	$57,923

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	29	108	$8,802
2016	75	408	$43,304
2017	61	386	$32,412
2018	40	298	$25,776
2019	32	204	$14,832
2020	27	235	$27,929
2021	38	273	$86,746
2022	91	513	$122,161
2023	73	469	$108,217
2024	71	400	$140,102

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	73	$1,328
2023	N/R	84	$1,525
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	36	102	$200
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	24	35	$159
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	34	44	$120
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	66	194	$73
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	22	28	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	30	1,980	$43,513
Farxiga	Dapagliflozin Propanediol	23	1,530	$28,438
Jardiance	Empagliflozin	16	1,080	$20,520
Eliquis	Apixaban	12	450	$8,403
Atorvastatin Calcium	Atorvastatin Calcium	33	2,070	$444

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$9,542	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ersilia M. Defilippis, M.D.?

Tedicare shows public-source Medicare data for Ersilia M. Defilippis, M.D. (NPI 1073994208), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ersilia M. Defilippis, M.D. have ACO affiliation data?

Ersilia M. Defilippis, M.D. is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Ersilia M. Defilippis, M.D.?

Ersilia M. Defilippis, M.D. is linked to TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (billing NPI 1861907321) in the available physician profile data.

Does Ersilia M. Defilippis, M.D. have Open Payments data?

Ersilia M. Defilippis, M.D. has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.